Cadila Healthcare Ltd

Consolidated EBITDA at ₹861 crore, up 6 per cent y-o-y

Focus on SBI Cards, HCL Tech, ACE, Cadila Healthcare, Adani Ports, RPP Infra, Indian Sucrose

Since vaccine development to EUA , Zydus Cadila stock surges 111%

With this approval, India now has its first Covid-19 vaccine for adolescents in the 12-18 age group

FPIs, mutual funds cut stake during Q1

Interim results from Phase III clinical trials demonstrate safety and efficacy for the 12-18 age group.

The drug to be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad

A single dose repurposed drug, when taken early, could help Covid patients recover faster and avoid complications seen in the advanced stages of the disease.

Company wraps up Phase-I/II trials, eyes start of Phase-III